Ponce School of Medicine; Caimed Center
Ponce 00716
1 studies enrolling now · 15 studies all time
What they study most
Cancer of the Lung, Carcinoma, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Diabetic Nephropathy, Growth and Tolerance, Hypertension, Lung Neoplasms, Metastatic Colorectal Cancer, Migraine, Neuropathic Pain, Non-Small-Cell Lung Carcinoma
Studies at this site
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
- A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT) — Completed
- Safety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Seronegative Adults — Completed
- Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain — Completed
- A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis — Completed
- A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura — Completed
- A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis — Completed
- A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes — Completed
- A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes — Completed
- A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis — Completed
- A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis — Completed
- Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer — Completed
- A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy — Completed
- Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone — Completed
- Growth and Tolerance of Infants Fed Infant Formulas — Completed